Search Tag: MASH

Cardiology Management

2025 07 May

New research published in the New England Journal of Medicine reveals that semaglutide effectively treats liver disease in nearly two-thirds of patients, offering new hope for those with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of liver disease.   MASH is a progressive form of Metabolic dysfunction-associated steatotic...Read more

Health Management

2024 23 Jul

  An overview of a new tool that converts highly validated ultrasound technology into a software-based application, enabling any clinician to assess and quantify liver stiffness at the point of care and democratise liver assessment—a critical need in light of the increasing prevalence and care burden of MASLD and MASH worldwide.   Key...Read more